Login | New Member? Signup Free
ChangeDetect » News

With New CEO, Silence Looks to Find Partners and Advance a New Drug into the Clinic

Having taken the helm of Silence Therapeutics after the departure of its second chief executive in less than a year, the company's newly appointed CEO Tony Sedgwick sees continued advancement of the phase I cancer drug Atu027 as one of his key goals.

Tags: , , , , , ,